SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-001127
Filing Date
2021-08-06
Accepted
2021-08-06 16:15:56
Documents
14
Period of Report
2021-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620849_8k-immunic.htm   iXBRL 8-K 20882
2 e620849_ex99-1.htm EX-99.1 87102
6 GRAPHIC image_001.jpg GRAPHIC 3365
  Complete submission text file 0001193805-21-001127.txt   299784

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imux-20210806.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imux-20210806_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imux-20210806_pre.xml EX-101.PRE 22350
7 EXTRACTED XBRL INSTANCE DOCUMENT e620849_8k-immunic_htm.xml XML 3695
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 211153088
SIC: 2834 Pharmaceutical Preparations